Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 042135/0651 | |
| Pages: | 3 |
| | Recorded: | 04/25/2017 | | |
| Attorney Dkt #: | BIOL0202WO/US.C1 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
2
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
12/13/2016
|
Application #:
|
14403103
|
Filing Dt:
|
11/21/2014
|
|
Publication #:
|
|
Pub Dt:
|
06/25/2015
| | |
PCT #:
|
US2013042163
|
|
Title:
|
MODULATION OF ENHANCER RNA MEDIATED GENE EXPRESSION
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
15283712
|
Filing Dt:
|
10/03/2016
|
|
Publication #:
|
|
Pub Dt:
|
08/10/2017
| | | | |
|
Title:
|
MODULATION OF ENHANCER RNA MEDIATED GENE EXPRESSION
|
|
|
Assignee
|
|
|
|
|
| 1111 FRANKLIN ST. |
| 5TH FLOOR |
| OAKLAND, CALIFORNIA 94607-5200 |
|
|
Correspondence name and address
|
| |
IONIS PHARMACEUTICALS, INC.
|
| |
2855 GAZELLE COURT
|
| |
CARLSBAD, CA 92010
|
Search Results as of:
05/07/2024 09:21 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
